Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 844 Views
-
Last post by NHE
-
- 0 Replies
- 1191 Views
-
Last post by NHE
-
- 0 Replies
- 2508 Views
-
Last post by frodo
-
- 1 Replies
- 1157 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1769 Views
-
Last post by NHE
-
- 0 Replies
- 1493 Views
-
Last post by frodo
-
- 0 Replies
- 2269 Views
-
Last post by vesta
-
- 1 Replies
- 1209 Views
-
Last post by Petr75
-
- 0 Replies
- 235 Views
-
Last post by NHE